TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
复制标题
TRIM59 通过抑制 STAT3 的 TC45 去磷酸化促进胶质瘤发生
DOI:
10.1158/0008-5472.can-17-2774
复制
发表时间:
2018-04-01
期刊:
影响因子:
11.2
通讯作者:
Feng H
中科院分区:
文献类型:
--
作者:
Sang Y;Li Y;Song L;Alvarez AA;Zhang W;Lv D;Tang J;Liu F;Chang Z;Hatakeyama S;Hu B;Cheng SY;Feng H
Aberrant epidermal growth factor receptor (EGFR) signaling is a common driver of glioblastoma (GBM) pathogenesis, however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells (GSCs). Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation.